Literature DB >> 23338229

Predictive factors for overall quality of life in patients with advanced cancer.

Gemma Cramarossa1, Edward Chow, Liying Zhang, Gillian Bedard, Liang Zeng, Arjun Sahgal, Vassilios Vassiliou, Takefumi Satoh, Palmira Foro, Brigette B Y Ma, Wei-Chu Chie, Emily Chen, Henry Lam, Andrew Bottomley.   

Abstract

OBJECTIVE: This study examined which domains/symptoms from the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 15 Palliative (QLQ-C15-PAL), an abbreviated version of the health-related EORTC QLQ-C30 questionnaire designed for palliative cancer patients, were predictive of overall quality of life (QOL) in advanced cancer patients.
METHODS: Patients with advanced cancer from six countries completed the QLQ-C15-PAL at consultation and at one follow-up point. Univariate and multivariate regression analyses were conducted to determine the predictive value of the EORTC QLQ-C15-PAL functional/symptom scores for global QOL (question 15).
RESULTS: Three hundred forty-nine patients completed the EORTC QLQ-C15-PAL at baseline. In the total patient sample, worse emotional functioning, pain, and appetite loss were the most significant predictive factors for worse QOL. In the subgroup of patients with bone metastases (n = 240), the domains mentioned above were also the most significant predictors, whereas in patients with brain metastases (n = 109), worse physical and emotional functioning most significantly predicted worse QOL. One-month follow-up in 267 patients revealed that the significant predictors changed somewhat over time. For example, in the total patient sample, physical functioning, fatigue, and appetite loss were significant predictors at the follow-up point. A sub-analysis of predictive factors affecting QOL by primary cancer (lung, breast, and prostate) was also conducted for the total patient sample.
CONCLUSION: Deterioration of certain EORTC QLQ-C15-PAL functional/symptom scores significantly contributes to worse overall QOL. Special attention should be directed to managing factors most influential on overall QOL to ensure optimal management of advanced cancer patients.

Entities:  

Mesh:

Year:  2013        PMID: 23338229     DOI: 10.1007/s00520-013-1717-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  30 in total

Review 1.  Fatigue in patients with advanced cancer: a review.

Authors:  E A Barnes; E Bruera
Journal:  Int J Gynecol Cancer       Date:  2002 Sep-Oct       Impact factor: 3.437

2.  A matter of definition--key elements identified in a discourse analysis of definitions of palliative care.

Authors:  T Pastrana; S Jünger; C Ostgathe; F Elsner; L Radbruch
Journal:  Palliat Med       Date:  2008-04       Impact factor: 4.762

3.  Quality of life and non-pain symptoms in patients with cancer.

Authors:  Marieke H J van den Beuken-van Everdingen; Janneke M de Rijke; Alfons G Kessels; Harry C Schouten; Maarten van Kleef; Jacob Patijn
Journal:  J Pain Symptom Manage       Date:  2009-06-28       Impact factor: 3.612

Review 4.  Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

Authors:  May N Tsao; Nancy S Lloyd; Rebecca K S Wong; Eileen Rakovitch; Edward Chow; Normand Laperriere
Journal:  Cancer Treat Rev       Date:  2005-06       Impact factor: 12.111

5.  Cancer pain: part 1: Pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners.

Authors:  Jon Raphael; Sam Ahmedzai; Joan Hester; Catherine Urch; Janette Barrie; John Williams; Paul Farquhar-Smith; Marie Fallon; Peter Hoskin; Karen Robb; Michael I Bennett; Rebecca Haines; Martin Johnson; Arun Bhaskar; Sam Chong; Rui Duarte; Elizabeth Sparkes
Journal:  Pain Med       Date:  2010-05       Impact factor: 3.750

6.  A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer.

Authors:  Junya Zhu; Roger B Davis; Sherri O Stuver; Donna L Berry; Susan Block; Jane C Weeks; Saul N Weingart
Journal:  Cancer       Date:  2012-06-06       Impact factor: 6.860

7.  Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy.

Authors:  Bee-Horng Lue; Tien-Shang Huang; Hsiu-Jung Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-31       Impact factor: 7.038

Review 8.  Skeletal complications of malignancy.

Authors:  R E Coleman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

9.  Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group.

Authors:  G Apolone; O Corli; A Caraceni; E Negri; S Deandrea; M Montanari; M T Greco
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

Review 10.  Fatigue and cancer: causes, prevalence and treatment approaches.

Authors:  L I Wagner; D Cella
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more
  17 in total

1.  Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.

Authors:  Peter A Kaufman; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Valerie Andre; Clemens Stoffregen; Sarah Shekarriz; Gregory L Price; Gebra Cuyun Carter; George W Sledge
Journal:  Oncologist       Date:  2019-10-24

2.  Fatigue scores in patients receiving palliative radiotherapy for painful bone metastases.

Authors:  Paul M Cheon; Natalie Pulenzas; Liying Zhang; Emma Mauti; Erin Wong; Nemica Thavarajah; May Tsao; Cyril Danjoux; Lori Holden; Carlo DeAngelis; Edward Chow
Journal:  Support Care Cancer       Date:  2014-12-24       Impact factor: 3.603

3.  EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.

Authors:  Yong Joo Lee; Sang-Yeon Suh; Youn Seon Choi; Jae Yong Shim; Ah-Ram Seo; Sung-Eun Choi; Hong-Yup Ahn; Eunji Yim
Journal:  Support Care Cancer       Date:  2014-03-01       Impact factor: 3.603

4.  Fatigue scores in patients with brain metastases receiving whole brain radiotherapy.

Authors:  Natalie Pulenzas; Luluel Khan; May Tsao; Liying Zhang; Breanne Lechner; Nemica Thavarajah; Elizabeth Barnes; Cyril Danjoux; Lori Holden; Natalie Lauzon; Parker Sheehan; Gillian Bedard; Edward Chow
Journal:  Support Care Cancer       Date:  2014-02-09       Impact factor: 3.603

5.  Quality of Life in Spanish advanced non-small-cell lung cancer patients: determinants of global QL and survival analyses.

Authors:  Juan Ignacio Arraras; Berta Hernandez; Maite Martinez; Koldo Cambra; Mikel Rico; Jose Juan Illarramendi; Antonio Viudez; Berta Ibañez; Uxue Zarandona; Enrique Martinez; Ruth Vera
Journal:  Springerplus       Date:  2016-06-22

6.  CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer.

Authors:  Vicki Tsianakas; Jenny Harris; Emma Ream; Mieke Van Hemelrijck; Arnie Purushotham; Lorelei Mucci; James S A Green; Jacquetta Fewster; Jo Armes
Journal:  BMJ Open       Date:  2017-02-15       Impact factor: 2.692

7.  Unmet supportive care needs and its relation to quality of life among adult acute leukaemia patients in China: a cross-sectional study.

Authors:  Yan Jie; Ying Wang; Jingyi Chen; Chunfeng Wang; Yingchun Lin; Rong Hu; Yong Wu
Journal:  Health Qual Life Outcomes       Date:  2020-06-23       Impact factor: 3.186

8.  Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.

Authors:  Rachel McDonald; Keyue Ding; Michael Brundage; Ralph M Meyer; Abdenour Nabid; Pierre Chabot; Genevieve Coulombe; Shahida Ahmed; Joda Kuk; A Rashid Dar; Aamer Mahmud; Alysa Fairchild; Carolyn F Wilson; Jackson S Y Wu; Kristopher Dennis; Carlo DeAngelis; Rebecca K S Wong; Liting Zhu; Stephanie Chan; Edward Chow
Journal:  JAMA Oncol       Date:  2017-07-01       Impact factor: 31.777

9.  CanWalk: study protocol for a randomized feasibility trial of a walking intervention for people with recurrent or metastatic cancer.

Authors:  Jenny Harris; Vicki Tsianakas; Emma Ream; Mieke Van Hemelrijck; Arnie Purushotham; Lorelei Mucci; James Sa Green; Karen Robb; Jacquetta Fewster; Jo Armes
Journal:  Pilot Feasibility Stud       Date:  2015-03-12

10.  An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement.

Authors:  Constanza Maximiano; Iker López; Cristina Martín; Luis Zugazabeitia; Juan L Martí-Ciriquián; Miguel A Núñez; Jorge Contreras; Michael Herdman; Susana Traseira; Mariano Provencio
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.